C-terminal truncation and Parkinson's disease-associated mutations down-regulate the protein serine/threonine kinase activity of PTEN-induced kinase-1
- PMID: 17000703
- DOI: 10.1093/hmg/ddl398
C-terminal truncation and Parkinson's disease-associated mutations down-regulate the protein serine/threonine kinase activity of PTEN-induced kinase-1
Abstract
The Parkinson's disease (PD) causative PINK1 gene encodes a mitochondrial protein kinase called PTEN-induced kinase 1 (PINK1). The autosomal recessive pattern of inheritance of PINK1 mutations suggests that PINK1 is neuroprotective and therefore loss of PINK1 function causes PD. Indeed, overexpression of PINK1 protects neuroblastoma cells from undergoing neurotoxin-induced apoptosis. As a protein kinase, PINK1 presumably exerts its neuroprotective effect by phosphorylating specific mitochondrial proteins and in turn modulating their functions. Towards elucidation of the neuroprotective mechanism of PINK1, we employed the baculovirus-infected insect cell system to express the recombinant protein consisting of the PINK1 kinase domain either alone [PINK1(KD)] or with the PINK1 C-terminal tail [PINK1(KD+T)]. Both recombinant enzymes preferentially phosphorylate the artificial substrate histone H1 exclusively at serine and threonine residues, demonstrating that PINK1 is indeed a protein serine/threonine kinase. Introduction of the PD-associated mutations, G386A and G409V significantly reduces PINK1(KD) kinase activity. Since Gly-386 and Gly-409 reside in the conserved activation segment of the kinase domain, the results suggest that the activation segment is a regulatory switch governing PINK1 kinase activity. We also demonstrate that PINK1(KD+T) is approximately 6-fold more active than PINK1(KD). Thus, in addition to the activation segment, the C-terminal tail also contains regulatory motifs capable of governing PINK1 kinase activity. Finally, the availability of active recombinant PINK1 proteins permits future studies to search for mitochondrial proteins that are preferentially phosphorylated by PINK1. As these proteins are likely physiological substrates of PINK1, their identification will shed light on the mechanism of pathogenesis of PD.
Similar articles
-
Analysis of the regulatory and catalytic domains of PTEN-induced kinase-1 (PINK1).Hum Mutat. 2012 Oct;33(10):1408-22. doi: 10.1002/humu.22127. Epub 2012 Jul 5. Hum Mutat. 2012. PMID: 22644621 Review.
-
Phylogenetic and in silico structural analysis of the Parkinson disease-related kinase PINK1.Hum Mutat. 2011 Apr;32(4):369-78. doi: 10.1002/humu.21444. Hum Mutat. 2011. PMID: 21412950
-
Biochemical aspects of the neuroprotective mechanism of PTEN-induced kinase-1 (PINK1).J Neurochem. 2008 Apr;105(1):18-33. doi: 10.1111/j.1471-4159.2008.05249.x. Epub 2008 Jan 23. J Neurochem. 2008. PMID: 18221368 Review.
-
Genetic mutations and functions of PINK1.Trends Pharmacol Sci. 2011 Oct;32(10):573-80. doi: 10.1016/j.tips.2011.06.001. Epub 2011 Jul 23. Trends Pharmacol Sci. 2011. PMID: 21784538 Review.
-
Discovery of catalytically active orthologues of the Parkinson's disease kinase PINK1: analysis of substrate specificity and impact of mutations.Open Biol. 2011 Nov;1(3):110012. doi: 10.1098/rsob.110012. Open Biol. 2011. PMID: 22645651 Free PMC article.
Cited by
-
Mitochondrial protein dysfunction in pathogenesis of neurological diseases.Front Mol Neurosci. 2022 Sep 7;15:974480. doi: 10.3389/fnmol.2022.974480. eCollection 2022. Front Mol Neurosci. 2022. PMID: 36157077 Free PMC article. Review.
-
Akt Phosphorylates NQO1 and Triggers its Degradation, Abolishing Its Antioxidative Activities in Parkinson's Disease.J Neurosci. 2019 Sep 11;39(37):7291-7305. doi: 10.1523/JNEUROSCI.0625-19.2019. Epub 2019 Jul 29. J Neurosci. 2019. PMID: 31358653 Free PMC article.
-
Autophagy regulation by RNA alternative splicing and implications in human diseases.Nat Commun. 2022 May 18;13(1):2735. doi: 10.1038/s41467-022-30433-1. Nat Commun. 2022. PMID: 35585060 Free PMC article. Review.
-
The effects of pdr1, djr1.1 and pink1 loss in manganese-induced toxicity and the role of α-synuclein in C. elegans.Metallomics. 2014 Mar;6(3):476-90. doi: 10.1039/c3mt00325f. Epub 2014 Jan 22. Metallomics. 2014. PMID: 24452053 Free PMC article.
-
PINK1 expression increases during brain development and stem cell differentiation, and affects the development of GFAP-positive astrocytes.Mol Brain. 2016 Jan 8;9:5. doi: 10.1186/s13041-016-0186-6. Mol Brain. 2016. PMID: 26746235 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials